Deficiencies in i-TECH study report

Wong Ang Peng

The I-TECH study was designed to study specifically advanced cases of Covid-19 patients, aged 50 and above and with at least one comorbidity, using low doses of ivermectin plus standard care compared to standard care alone.– AFP pic, November 9, 2021.

THE results of the just released summarised report of the Health Ministry’s I-TECH (Ivermectin Treatment Efficacy in Covid-19 High Risk Patients) are as anticipated, a construct of hidden truth, and currently irrelevant. There are several deficiencies in the report.

Those familiar with research methodology had anticipated that the outcome of the I-TECH study would be statistically non-significant because it was underpowered (n=500).

Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!

Sign up or sign in here to comment.